Evidence map›Paper›PMID 35052836›Full record

ArticleBiomedicines2022

Canthaxanthin Biofabrication, Loading in Green Phospholipid Vesicles and Evaluation of In Vitro Protection of Cells and Promotion of Their Monolayer Regeneration.

Ines Castangia, Maria Letizia Manca, Seyed Hadi Razavi, Amparo Nácher, Octavio Díez-Sales, José Esteban Peris, Mohamad Allaw, Maria Carmen Terencio, Iris Usach, Maria Manconi

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Liposomal Delivery of a BiotechnologicalAntioxidants (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Ines CastangiaDepartment Scienze della Vita e dell'Ambiente, University of Cagliari, 09124 Cagliari, Italy.
Maria Letizia MancaDepartment Scienze della Vita e dell'Ambiente, University of Cagliari, 09124 Cagliari, Italy.ORCID 0000-0002-3787-257X
Seyed Hadi RazaviBioprocess Engineering Laboratory (BPEL), Department of Food Science, Engineering & Technology, Faculty of Agricultural Engineering and Technology, University of Tehran, P.O. Box 4111, Karaj 31587-77871, Iran.ORCID 0000-0002-5815-4411
Amparo NácherDepartment of Pharmacy and Pharmaceutical Technology, University of Valencia, 46100 Valencia, Spain.ORCID 0000-0002-1707-7966
Octavio Díez-SalesDepartment of Pharmacy and Pharmaceutical Technology, University of Valencia, 46100 Valencia, Spain.
José Esteban PerisDepartment of Pharmacy and Pharmaceutical Technology, University of Valencia, 46100 Valencia, Spain.
Mohamad AllawDepartment Scienze della Vita e dell'Ambiente, University of Cagliari, 09124 Cagliari, Italy.
Maria Carmen TerencioDepartment of Pharmacy and Pharmaceutical Technology, University of Valencia, 46100 Valencia, Spain.ORCID 0000-0003-3800-6048
Iris UsachDepartment of Pharmacy and Pharmaceutical Technology, University of Valencia, 46100 Valencia, Spain.
Maria ManconiDepartment Scienze della Vita e dell'Ambiente, University of Cagliari, 09124 Cagliari, Italy.ORCID 0000-0003-4818-2344
Universitat de València · ESUniversity of Cagliari · ITUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, canthaxanthin was produced by biofermentation from Dietzia natronolimnaea HS-1 (D. natronolimnaea) and was loaded in phospholipid vesicles prepared with natural component using an easy and low dissipative method. Indeed, glycerosomes, hyalurosomes, and glycerohyalurosomes were prepared by direct hydration of both phosphatidylcholine and the biotechnological canthaxanthin, avoiding the use of organic solvents. Vesicles were sized from 63 nm to 87 nm and highly negatively charged. They entrapped a high number of the biomolecules and were stable on storage. Canthaxanthin-loaded vesicles incubated with fibroblasts did not affect their viability, proving to be highly biocompatible and capable of inhibiting the death of fibroblasts stressed with hydrogen peroxide. They reduced the nitric oxide expression in macrophages treated with lipopolysaccharides. Moreover, they favoured the cell migration in an in vitro lesion model. Results confirmed the health-promoting potential of canthaxanthin in skin cells, which is potentiated by its suitable loading in phospholipid vesicles, thus suggesting the possible use of these natural bioformulations in both skin protection and regeneration, thanks to the potent antioxidant, anti-inflammatory and antiageing effects of canthaxanthin.

Indexed as

canthaxanthinDietzia natronolimnaea HS-1fibroblastsGriess reagenthydrogen peroxidemacrophagesskin delivery

Identifiers

PMID35052836
PMCPMC8773935
OpenAlexW4205388064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.